Drug Manufacturing
NEWS
Lotus Pharmaceuticals Issues New Patent For Controlled-Release Diabetes Drug
Lotus Pharmaceuticals Inc has announced that its wholly owned subsidiary En Ze Jia Shi Pharmaceuticals has been issued a patent for controlledrelease of oral gliclazide which is commonly used to control mild to moderate adultonset Type diabetes The patent that covers the composition and preparation methods for the drug through has been issued...
